Singular Health Valuation
| SHG Stock | 0.25 0.01 3.85% |
Singular Health seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Singular Health Group from inspecting the company fundamentals such as Current Valuation of 63.81 M, return on equity of -1.63, and Price To Book of 13.56 X as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 13.5561 | Enterprise Value 63.8 M | Enterprise Value Ebitda (1.47) | Price Sales 71.1291 | Enterprise Value Revenue 15.1295 |
Overvalued
Today
Please note that Singular Health's price fluctuation is out of control at this time. Calculation of the real value of Singular Health Group is based on 3 months time horizon. Increasing Singular Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Singular Health's intrinsic value may or may not be the same as its current market price of 0.25, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.21 | Hype 0.25 | Naive 0.26 |
The intrinsic value of Singular Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Singular Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Singular Health Group helps investors to forecast how Singular stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Singular Health more accurately as focusing exclusively on Singular Health's fundamentals will not take into account other important factors: Singular Health Cash |
|
Singular Health Total Value Analysis
Singular Health Group is at this time forecasted to have takeover price of 63.81 M with market capitalization of 62.45 M, debt of 218.45 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Singular Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
63.81 M | 62.45 M | 218.45 K |
Singular Health Investor Information
About 37.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. Singular Health Group had not issued any dividends in recent years. Singular Health Group is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Singular Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Singular Health has an asset utilization ratio of 3.86 percent. This implies that the Company is making USD0.0386 for each dollar of assets. An increasing asset utilization means that Singular Health Group is more efficient with each dollar of assets it utilizes for everyday operations.Singular Health Ownership Allocation
Singular Health Group shows a total of 260.2 Million outstanding shares. Singular Health Group maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Singular Health Profitability Analysis
The company reported the revenue of 90.83 K. Net Loss for the year was (2.88 M) with profit before overhead, payroll, taxes, and interest of 318.96 K.About Singular Health Valuation
The stock valuation mechanism determines Singular Health's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Singular Health Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Singular Health. We calculate exposure to Singular Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Singular Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.4 M | -2.5 M |
Additional Tools for Singular Stock Analysis
When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.